The CDMRP grant complements a $9.2M contract from the Defense Threat Reduction Agency awarded last year to MeMed that is supporting the final stages of prototype development. (Logo: http ...

Funds will be used to complete the development of first ever point of care platform to distinguish bacterial from viral infections MeMed Ltd. announced today that it has been awarded a contract by ...